0.31% -0.010

Nyxoah Sa (NYXH)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Nyxoah Sa Stock (NYXH) Company Profile

Healthcare (1113)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NYXH's Discussions on Twitter

Compare NYXH vs ISRG, BDX, MDLN, ALC, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NYXH Nyxoah Sa	3.22	140.59M	11.51M	-101.84M	-82.98M	-2.6714
ISRG Intuitive Surgical Inc	451.29	160.28B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	156.69	44.57B	21.92B	1.76B	2.63B	6.1223
MDLN Medline Inc	47.51	38.56B	28.43B	1.16B	1.26B	1.4457
ALC Alcon Inc	77.82	37.93B	10.40B	980.00M	1.61B	1.9749
RMD Resmed Inc	221.22	32.23B	5.40B	1.49B	1.78B	10.12

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-07-31	Eingeleitet	H.C. Wainwright	Buy
2023-07-19	Eingeleitet	Robert W. Baird	Neutral
2022-04-21	Eingeleitet	Oppenheimer	Outperform
2022-04-06	Eingeleitet	Wolfe Research	Peer Perform
2021-12-21	Fortgesetzt	Cantor Fitzgerald	Overweight
2021-07-28	Eingeleitet	Cantor Fitzgerald	Overweight

Alle ansehen

Nyxoah Sa Aktie (NYXH) Neueste Nachrichten

Finanzdaten der Nyxoah Sa-Aktie (NYXH)

Nyxoah Sa (NYXH)

Nyxoah Sa Stock (NYXH) Company Profile

Compare NYXH vs ISRG, BDX, MDLN, ALC, RMD

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Nyxoah Sa Aktie (NYXH) Neueste Nachrichten

Baird lowers its price target on Nyxoah SA (NYXH) to $4.62 from $5.87 - MSN

Nyxoah SA (NYXH) Stock Analysis: Exploring a 208% Potential Upside in the Medical Tech Sector - DirectorsTalk Interviews

Aug PreEarnings: Is Nyxoah SA forming bullish engulfing patterns2026 Price Momentum & AI Powered Trade Plan Recommendations - baoquankhu1.vn

Nyxoah SA (NYXH) reports Q4 loss, misses revenue estimates - MSN

Baird Maintains Nyxoah SA(NYXH.US) With Hold Rating, Cuts Target Price to $4.62 - 富途牛牛

Today's Analyst Ratings for Nyxoah (NYXH): Stock Price Target Lo - GuruFocus

Stifel cuts Nyxoah stock price target to $8 on valuation review - Investing.com Canada

Stifel cuts Nyxoah stock price target to $8 on valuation review By Investing.com - Investing.com South Africa

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 - NTB Kommunikasjon

Market Overview: Can Nyxoah SA expand into new marketsPortfolio Gains Report & Consistent Profit Alerts - baoquankhu1.vn

Growth Review: Is now the right time to enter Nyxoah SA2026 Levels & AI Powered Market Trend Analysis - baoquankhu1.vn

Aug Breakouts: Will Nyxoah SA benefit from AI trendsWeekly Gains Report & AI Based Buy and Sell Signals - baoquankhu1.vn

NYXH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Baird Lowers its Price Target on Nyxoah SA (NYXH) to $4.62 from $5.87 - Insider Monkey

Nyxoah’s Earnings Call Shows Rapid Growth, Rising Risks - TipRanks

NYXH PE Ratio & Valuation, Is NYXH Overvalued - Intellectia AI

Buyout Rumor: Is Nyxoah SA stock undervalued right now2026 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn

Exit Recap: Will Nyxoah SA benefit from AI trendsEarnings Performance Report & Fast Exit Strategy with Risk Control - baoquankhu1.vn

Nyxoah SA (NASDAQ:NYXH) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Cantor Fitzgerald Initiates Nyxoah SA(NYXH.US) With Buy Rating, Announces Target Price $11 - 富途牛牛

[20-F] Nyxoah SA Files Annual Report (Foreign Issuer) | NYXH SEC FilingForm 20-F - stocktitan.net

Bull Run: Can Nyxoah SA ride the EV waveShare Buyback & Accurate Buy Signal Notifications - baoquankhu1.vn

Retail Trends: Is now the right time to enter Nyxoah SAMarket Risk Analysis & Long-Term Safe Return Strategies - baoquankhu1.vn

Breakout Zone: Is Nyxoah SA a speculative investment2026 Rallies & Entry Point Strategy Guides - baoquankhu1.vn

Nyxoah sees Q2 revenue up 73%, plans R&D shift to U.S. and Belgium; shares rise - MSN

Cantor Fitzgerald Reiterates Overweight Rating for NYXH, Price T - gurufocus.com

Cantor Fitzgerald reiterates Nyxoah stock rating on U.S. launch - Investing.com UK

Nyxoah's (NYXH) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat

Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $10 - 富途牛牛

New Highs: Will Nyxoah SA benefit from rising consumer demandQuarterly Risk Review & Reliable Intraday Trade Plans - baoquankhu1.vn

Nyxoah Details Early U.S. Genio Launch, Reimbursement Update at Oppenheimer MedTech Conference 2026 - MarketBeat

Nyxoah (ENXTBR:NYXH) Losses Of €90 Million Keep Bearish Cash Runway Concerns In Focus - simplywall.st

Nyxoah Discloses Taub Group’s 10.14% Stake After Threshold Crossing - TipRanks

Publication relating to transparency notifications - GlobeNewswire

Stifel Nicolaus Issues Pessimistic Forecast for Nyxoah (NASDAQ:NYXH) Stock Price - MarketBeat

Nyxoah (NYXH) Q4 2025 Earnings Call Transcript - AOL.com

NYXH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Nyxoah SA (NYXH) Q4 2025 Earnings Call Highlights: U.S. Launch Success and Financial Challenges By GuruFocus - Investing.com Canada

Nyxoah (NASDAQ:NYXH) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat

Nyxoah Q4 2025 Earnings Call Transcript - MarketBeat

Nyxoah SA reports results for the quarter ended December 31Earnings Summary - TradingView

NYXH: FDA approval and U.S. launch fueled 122% revenue growth and strong Q4 momentum - TradingView

Nyxoah Q4 Earnings Call Highlights - MarketBeat

Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

NYXH: Transformative U.S. launch drove 122% revenue growth and strong Q4 momentum - TradingView

Nyxoah Leverages First Full U.S. Sales Quarter to Power Triple-Digit 2025 Revenue Growth - TipRanks

Nyxoah (NASDAQ: NYXH) doubles 2025 revenue as U.S. launch drives growth but losses deepen - Stock Titan

Nyxoah SA Provides Revenue Guidance for the First Quarter and Second Quarter of 2026 - MarketScreener

Finanzdaten der Nyxoah Sa-Aktie (NYXH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie NYXH